Scientists find clues on why COVID vaccine causes chronic health problems in some
For a majority of people, the COVID vaccine doesn't cause adverse health effects — but a small percentage experience chronic symptoms that can last for months or even years.
Yale researchers recently made some discoveries about why certain people experience this condition, which they have dubbed "post-vaccination syndrome" (PVS).
In early findings, the team recognized "potential immunological patterns" that are unique to people with PVS. The hope is that this discovery will help to enable future treatments and therapies for those who are affected.
Is Mmr Vaccine Safe For Kids? Dr. Nicole Saphier Addresses Concerns As Measles Cases Rise
"This work is still in its early stages, and we need to validate these findings," said co-senior study author Akiko Iwasaki, Sterling Professor of Immunobiology at Yale School of Medicine, in a press release.
"But this is giving us some hope that there may be something that we can use for diagnosis and treatment of PVS down the road."
Read On The Fox News App
People with this condition may suffer from excessive fatigue, exercise intolerance, brain fog, insomnia and dizziness, according to the Yale researchers.
These typically develop within a day or two of vaccination and can worsen over time.
New Bat Coronavirus Discovered In China Sparks Pandemic Concerns
"It's clear that some individuals are experiencing significant challenges after vaccination. Our responsibility as scientists and clinicians is to listen to their experiences, rigorously investigate the underlying causes, and seek ways to help," said co-senior author Harlan Krumholz, professor of cardiology at YSM, in the release.
"Post-vaccination syndrome is real, and has been found [to occur] from many vaccines, including COVID," Dr. Marc Siegel, clinical professor of medicine at NYU Langone Health and Fox News senior medical analyst, told Fox News Digital.
The researchers analyzed blood samples from 42 study participants who experienced symptoms of PVS and 22 who did not.
Those with symptoms were shown to have lower levels of two types of white blood cells. People with PVS who had never had COVID also had lower levels of antibodies against the SARS-CoV-2 spike protein, likely because they tended to have fewer vaccine doses, according to the release.
"Fewer vaccine doses and no viral infection means the body's immune system has had little opportunity to develop a defense to the virus," said the researchers.
Some of the people with PVS also had higher levels of the SARS-CoV-2 spike protein, which enables the virus to penetrate and infect host cells. This has also been linked to a higher risk of developing long COVID.
"We don't know if the level of spike protein is causing the chronic symptoms, because there were other participants with PVS who didn't have any measurable spike protein — but it could be one mechanism underlying this syndrome," said Iwasaki.
In addition to the elevated spike proteins, other factors could increase the risk of post-vaccination syndrome. Those include autoimmunity, tissue damage and reactivation of Epstein-Barr virus (EBV), the researchers wrote.
"Akiko Iwasaka is a world-renowned immunologist at Yale who has studied COVID (and COVID vaccines) extensively," Siegel pointed out.
Click Here To Sign Up For Our Health Newsletter
"In this new study, she reports that in a very small percentage of those who received COVID vaccines (and experienced prolonged side effects), there may be the presence of persistent spike protein," Siegel confirmed.
"They may also experience immune disruption, which takes the form of elevations in inflammatory immune cells (CD8 and TN alpha) and a decrease in cells that help resolve inflammation and infection (CD4 helper cells)."
The researchers agreed that more studies are essential to guide diagnosis and treatment.
"We're only just starting to make headway in understanding PVS," said Krumholz. "Every medical intervention carries some risk, and it's important to acknowledge that adverse events can occur with vaccines."
For more Health articles, visit www.foxnews.com/health
"Our focus must remain on understanding what these people are experiencing through rigorous science and addressing the needs of those affected with compassion and an open mind."
Siegel agreed, adding, "This needs to be further studied in terms of understanding how common prolonged COVID vaccine side effects are and how to predict them and treat them."Original article source: Scientists find clues on why COVID vaccine causes chronic health problems in some
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Gizmodo
19 minutes ago
- Gizmodo
RFK Jr. Purges CDC's Vital Vaccine Advisory Committee
On Monday afternoon, the head of HHS enacted a "clean sweep" of the Advisory Committee on Immunization Practices. Robert F. Kennedy Jr. is continuing his ideological purge of the federal government. The Health and Human Services Secretary just terminated all 17 members of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP)—the outside experts who help steer the country's vaccine policies. Kennedy announced the firings late Monday afternoon in an editorial published by the Wall Street Journal. He argued that by 'retiring' the ACIP's current members, he would restore the public's trust in vaccines. However, RFK Jr. himself has long overexaggerated the dangers of vaccination, and experts worry that he will stock the ACIP with anti-vaccination proponents. 'Today's action to remove the 17 sitting members of ACIP undermines…trust and upends a transparent process that has saved countless lives,' said Bruce Scott, president of the American Medical Association, in a statement provided to Gizmodo. 'With an ongoing measles outbreak and routine child vaccination rates declining, this move will further fuel the spread of vaccine-preventable illnesses.' The ACIP is a panel of outside experts assembled by the CDC. Their recommendations, formally adopted by the CDC, greatly influence which vaccines are routinely provided to the public. States often mandate that children receive vaccines universally recommended by the ACIP, such as the measles, mumps, and rubella (MMR) vaccine, before they can enter public school, for instance. Insurance plans are also typically required to cover ACIP-recommended vaccines without any cost-sharing. For two decades, RFK Jr. has regularly misrepresented the evidence on vaccine safety and other important health issues. And it didn't take long for him to signal that he would undermine the country's vaccine policies. In his opening speech as the head of HHS in mid-February, Kennedy stated that he would form a commission to investigate the childhood vaccine schedule as a potential culprit of chronic disease (no strong evidence supports a connection between the vaccine schedule and a population-level rise in chronic illness). Kennedy has previously argued that the ACIP's current and former members were rife with conflicts of interest, such as having received money from vaccine manufacturers. During the Senate committee hearings this January, for instance, he claimed that 97% of ACIP members had these conflicts—an unsurprisingly misleading claim. Kennedy was wrongly citing a 2009 report that found 97% of financial disclosure forms from people on advisory committees in 2007 had at least one error or omission, such as missing dates. Kennedy's latest WSJ editorial correctly describes the 97% statistic, though he still appears to imply these omissions are largely undeclared financial conflicts (the 2009 report found that 15% of members did not comply with ethics requirements during their committee stints). Aside from eliding the truth about the ACIP's ethical standards, Kennedy seems to have outright broken his promise to Senator Bill Cassidy (R-Louisiana) that he would 'maintain' the ACIP without changes—a promise that secured Cassidy's pivotal tiebreaker vote in early February to further his nomination through the Senate. On a X post late Monday, Cassidy acknowledged many people's fears that the ACIP will now 'be filled up with people who know nothing about vaccines except suspicion.' But Cassidy didn't acknowledge the broken promise, only stating that he would continue talking with Kennedy to 'ensure that this is not the case.' Of course, now the fear is that the ACIP will be filled up with people who know nothing about vaccines except suspicion. I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the — U.S. Senator Bill Cassidy, M.D. (@SenBillCassidy) June 9, 2025 Of course, there's little reason to believe that RFK Jr's antivax agenda will be meaningfully constrained by anyone in the government. He's already enacted a renewed investigation into the debunked link between vaccines and autism—an investigation that will be led by notorious vaccine skeptic David Geier. Kennedy and the Trump administration have also impeded the development of newer, possibly more effective vaccines for both flu and covid-19, and are attempting to place testing roadblocks that will make future vaccine approvals harder to secure.
Scientific American
21 minutes ago
- Scientific American
Can You Still Get a COVID Vaccine This Fall? Here's What to Know
For the first time since the COVID vaccines became available in pharmacies in 2021, the average person in the U.S. can't count on getting a free annual shot against a disease that has been the main or a contributing cause of death for more than 1.2 million people around the country, including nearly 12,000 to date this year. 'COVID's not done with us,' says Jennifer Nuzzo, an epidemiologist at Brown University. 'We have to keep using the tools that we have. It's not like we get to forget about COVID.' In recent weeks, the Department of Health and Human Services, led by prominent antivaccine activist Robert F. Kennedy, Jr., has announced a barrage of measures that are likely to reduce COVID vaccine access, leading to a swirl of confusion about what will be available for the 2025–2026 season. HHS officials did not respond to a request for comment for this article. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. Government officials appear to be limiting COVID shots to people who are aged 65 and older and to those who have certain preexisting health conditions—groups that have long been known to face a higher risk of developing severe COVID. Pregnant people and some children, meanwhile, appear to be explicitly excluded from access, despite plentiful evidence that vaccines are very safe and effective for them and that COVID infections can cause them significant harm. Scientific American spoke with clinicians and public health experts about the latest COVID vaccine recommendations, what access may look like this fall and how these policies might influence people's vaccination choices and health. What COVID vaccines will be manufactured this year? Public health experts are monitoring a strain of the COVID-causing virus SARS-CoV-2 called NB.1.8.1, which was first detected early this year and last month became responsible for one in 10 COVID cases globally. So far, the new variant has mostly been reported in Asia and Europe. But it has also been picked up in airport surveillance in multiple U.S. states, says Peter Chin-Hong, an infectious disease physician and a professor of medicine at the University of California, San Francisco. The emergence of a new variant isn't surprising, particularly at this time of year, Chin-Hong says. 'It's kind of acting like clockwork—maybe this might be the variant of the summer,' he adds. Still, NB.1.8.1 has led to concerns about a potential surge in cases—although Chin-Hong and other scientists don't have any evidence so far that it causes more serious disease than other currently circulating strains. 'All of these new variants, they might be more transmissible, they might be more immune evasive, but I've seen no data whatsoever that suggests that they're more pathogenic,' says Angela Rasmussen, a virologist at the University of Saskatchewan. Within the U.S., a strain called LP.8.1 has been the most common one detected since March. Both NB.1.8.1 and LP.8.1 are among the alphabet soup of strains that descended from a key ancestor lineage called Omicron JN.1, which dominated U.S. cases by early 2024. Current vaccines target this category of strains. And in May a Food and Drug Administration panel determined that, this year, vaccine producers should again tailor their shots to a single strain within the JN.1 lineage—preferably LP.8.1. What's going on with COVID vaccine policy? Strain selection aside, the recent messaging and decision-making on vaccine policy for COVID and beyond have been chaotic, with various governmental groups and officials announcing different access guidelines and restrictions. 'The situation we're in right now is nuts,' says Nuzzo, referring to the fact that agency leaders have sidestepped the formal science committees that traditionally make vaccine-related decisions. 'We don't change vaccine policy on a willy-nilly basis. There's an incredible amount of nuance, and all of the data need to be considered.' But on June 9 Kennedy took a major step against this evidence-driven decision-making process by firing the entire CDC Advisory Committee on Immunization Practices (ACIP). Kennedy announced the committee rehaul in a Wall Street Journal op-ed, in which he alleged there were 'persistent conflicts of interest' among committee members. According to a recent HHS statement, new committee members are under consideration, and the group will still meet as scheduled from June 25 to 27. ACIP has traditionally been particularly important because any vaccine it recommends must be fully paid for by health insurance companies—a condition that greatly determines real-world access. It's unclear what the committee's overhaul will mean for COVID vaccine access in particular. Another concern is that Kennedy announced in late April that HHS would implement a policy requiring all 'new' vaccines—including updated versions of existing ones, such as COVID shots—to be tested against a placebo. The original COVID vaccines were tested in just this manner. But conducting similar tests when an effective and very safe vaccine already exists would be not only unethical for researchers but also expensive and time-consuming for manufacturers. It remains unclear when the new policy will take effect. What does this mean for COVID vaccine access this fall? If you are 65 years old or older, you should be able to get a COVID shot as you have in recent years. If you have an underlying condition such as cancer, diabetes, or heart or lung problems, you may also be able to get a COVID shot as usual. These issues and several others are on the CDC's list of conditions that leave people more vulnerable to severe disease, and this list is included in the description of the new regulatory framework. One 2021 study looked at many (but not all) of the conditions on the list and estimated that three in four U.S. adults has at least one. People are allowed to self-disclose a preexisting condition at pharmacies without a prescription or doctor's note. That list could also be expanded later if new research finds other risk factors that increase people's risk of severe COVID, says Jacinda Abdul-Mutakabbir, a clinical pharmacist and an assistant professor at the University of California, San Diego. But there's also a chance that qualifying conditions may be reduced instead. For example, current or recent pregnancy is included in the CDC's existing list, but HHS officials announced in late May that the COVID vaccine would no longer be recommended for pregnant people. Data have shown that COVID may cause various complications during pregnancy —increasing the risk that the pregnant person may require emergency care, be put on a ventilator or die. The newborn child of an infected person is also more likely to be born preterm or to have low birth weight. And babies younger than six months old—who are ineligible for vaccination because of their immature immune system—have the highest rates COVID hospitalization after adults aged 75 and older. In contrast, evidence from people vaccinated during pregnancy show that newborns receive protective immunity through antibodies that cross the placenta and are found in breast milk, Chin-Hong explains. Healthy children also face new restrictions to COVID vaccine access: The shot is now only recommended to them based on 'shared clinical decision-making,' according to the vaccine schedules released by the CDC last month. This means parents must consult with a health practitioner about whether to vaccinate such children. Experts worry about the consequences of restricting access for kids. Children under age 18 make up a smaller percentage of COVID hospitalizations and deaths. But that doesn't mean zero risk, Chin-Hong says. 'We know that COVID still kills kids,' he says. 'No death of a child is a good death—and these are all preventable.' 'Because children and pregnant people are considered vulnerable populations, they were not included in the original studies that were done for the COVID vaccines,' Abdul-Mutakabbir says. But five years' worth of real-world vaccine data from these groups show the health benefits. 'We do see effectiveness and safety in these vaccines,' she says. It's still possible that the late June ACIP meeting will shift the landscape again. But if you want a COVID vaccine this fall and don't meet current guidelines, you may still be able to request a shot. Your insurance may not pay for it, however, leaving you to risk a price tag of around $200. 'Insurance companies or providers are only required to pay for vaccines that are listed as recommended by the CDC,' Abdul-Mutakabbir says. Full, partial or no-cost coverage for nonrecommended vaccines is at the insurance provider's discretion. Any changes to coverage—and the times at which those changes are announced—will vary among programs, including private and governmental ones, such as the federal-state program Medicaid and the federal program Medicare. Until then, Chin-Hong and Abdul-Mutakabbir say, the COVID vaccines released in the fall of 2024 are still recommended and available to people who haven't already had one. And as of April 26, only 23 percent of adults and 13 percent of children in the U.S. had received the shot. 'If you are nervous about the surge or planning summer travel, I would recommend' getting the vaccine, Abdul-Mutakabbir says. The larger fight over vaccines For Rasmussen, the confusion over COVID shots signals the beginning of a longer tug-of-war—with Kennedy's HHS on one end. 'I think I know what their plan is, and it's to reduce access to vaccines in general,' she says. 'In my view, this is an incremental step in a larger attack on vaccination in general.' She encourages people worried about vaccine restrictions—and about the role of science in making these decisions—to call their congressional legislators. 'A lot of people speaking out is what is needed right now to make a big difference here,' she says. Abdul-Mutakabbir also hopes people continue to seek vaccines for COVID and other diseases—especially while they are still easily available. 'It's important that we consider the things that we can protect ourselves against,' Abdul-Mutakabbir says. 'Should you have a barrier with getting a COVID vaccine, guess what? There's no change to the flu vaccine; there's no changes to the pneumococcal recommendations; there's no change to measles, mumps, rubella vaccine. Get the vaccines that we can get.'
New York Times
34 minutes ago
- New York Times
F.D.A. Looks to A.I. to Enhance Efficiency
The Food and Drug Administration is planning to use artificial intelligence to 'radically increase efficiency' in deciding whether to approve new drugs and devices, one of several top priorities laid out in an article published Tuesday in JAMA. Another initiative involves a review of chemicals and other 'concerning ingredients' that appear in U.S. food but not in the food of other developed nations. And officials want to speed up the final stages of making a drug or medical device approval decision to mere weeks, citing the success of Operation Warp Speed during the Covid pandemic when workers raced to curb a spiraling death count. 'The F.D.A. will be focused on delivering faster cures and meaningful treatments for patients, especially those with neglected and rare diseases, healthier food for children and common-sense approaches to rebuild the public trust,' Dr. Marty Makary, the agency commissioner, and Dr. Vinay Prasad, who leads the division that oversees vaccines and gene therapy, wrote in the JAMA article. The agency plays a central role in pursuing the agenda of the U.S. health secretary, Robert F. Kennedy Jr., and it has already begun to press food makers to eliminate artificial food dyes. The new road map also underscores the Trump administration's efforts to smooth the way for major industries with an array of efforts aimed at getting products to pharmacies and store shelves quickly. Some aspects of the proposals outlined in JAMA were met with skepticism, particularly the idea that artificial intelligence is up to the task of shearing months or years from the painstaking work of examining applications that companies submit when seeking approval for a drug or high-risk medical device. 'I don't want to be dismissive of speeding reviews at the F.D.A.,' said Stephen Holland, a lawyer who formerly advised the House Committee on Energy and Commerce on health care. 'I think that there is great potential here, but I'm not seeing the beef yet.' Want all of The Times? Subscribe.
